HANCOCK DANIEL M 4
4 · Cryoport, Inc. · Filed Sep 29, 2021
Insider Transaction Report
Form 4
Cryoport, Inc.CYRX
HANCOCK DANIEL M
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2021-09-27$14.35/sh+10,000$143,500→ 14,627 total - Sale
Common Stock
[F1][F2]2021-09-27$70.17/sh−10,000$701,722→ 4,627 total - Exercise/Conversion
Option to purchase common stock
[F1][F3]2021-09-27−10,000→ 15,000 totalExercise: $14.35Exp: 2029-05-02→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.65 to $70.47, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month for the twelve (12) months beginning on 05/02/2019.
Signature
/s/ Daniel Hancock|2021-09-29